Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: China Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20073
20083
20092
20111
20121
20131
20141
20152
20163
20176
20185
20198
20208
20218
20224
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated65

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
BeiGene3
Sun Yat-sen University3
AstraZeneca2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Merck Sharp & Dohme LLC2
Peking University First Hospital2
Pfizer2
ABM Therapeutics Shanghai Company Limited1
Accuray Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung65
Lung Neoplasms6
Melanoma3
Neoplasm Metastasis3
Carcinoma2
Carcinoma, Squamous Cell2
Carcinoma, Transitional Cell2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma1
Anemia1

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.